CENTURY ALUMINUM COMPANY (CENX)

US1564311082 - Common Stock

18.33  +0.27 (+1.5%)

After market: 18.33 0 (0%)

Fundamental Rating

3

Overall CENX gets a fundamental rating of 3 out of 10. We evaluated CENX against 156 industry peers in the Metals & Mining industry. While CENX is still in line with the averages on profitability rating, there are concerns on its financial health. CENX has a correct valuation and a medium growth rate.



5

1. Profitability

1.1 Basic Checks

In the past year CENX was profitable.
In the past year CENX had a positive cash flow from operations.
In the past 5 years CENX always reported negative net income.
Of the past 5 years CENX 4 years had a positive operating cash flow.

1.2 Ratios

CENX has a better Return On Assets (16.13%) than 96.15% of its industry peers.
Looking at the Return On Equity, with a value of 46.91%, CENX belongs to the top of the industry, outperforming 98.08% of the companies in the same industry.
CENX has a Return On Invested Capital of 5.56%. This is in the better half of the industry: CENX outperforms 65.38% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CENX is significantly below the industry average of 8.89%.
The last Return On Invested Capital (5.56%) for CENX is above the 3 year average (2.82%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 16.13%
ROE 46.91%
ROIC 5.56%
ROA(3y)-4.65%
ROA(5y)-5.63%
ROE(3y)-18.45%
ROE(5y)-17.98%
ROIC(3y)2.82%
ROIC(5y)N/A

1.3 Margins

CENX has a Profit Margin of 14.55%. This is amongst the best in the industry. CENX outperforms 87.18% of its industry peers.
The Operating Margin of CENX (4.80%) is comparable to the rest of the industry.
CENX has a Gross Margin of 7.52%. This is in the lower half of the industry: CENX underperforms 60.26% of its industry peers.
Industry RankSector Rank
OM 4.8%
PM (TTM) 14.55%
GM 7.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CENX is destroying value.
Compared to 1 year ago, CENX has more shares outstanding
Compared to 5 years ago, CENX has more shares outstanding
Compared to 1 year ago, CENX has an improved debt to assets ratio.

2.2 Solvency

CENX has an Altman-Z score of 1.04. This is a bad value and indicates that CENX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.04, CENX is doing worse than 71.15% of the companies in the same industry.
A Debt/Equity ratio of 0.70 indicates that CENX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.70, CENX is not doing good in the industry: 83.97% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Altman-Z 1.04
ROIC/WACC0.5
WACC11.08%

2.3 Liquidity

CENX has a Current Ratio of 1.71. This is a normal value and indicates that CENX is financially healthy and should not expect problems in meeting its short term obligations.
CENX's Current ratio of 1.71 is on the low side compared to the rest of the industry. CENX is outperformed by 66.03% of its industry peers.
A Quick Ratio of 0.56 indicates that CENX may have some problems paying its short term obligations.
With a Quick ratio value of 0.56, CENX is not doing good in the industry: 88.46% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 0.56

4

3. Growth

3.1 Past

CENX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 356.41%, which is quite impressive.
The Revenue has decreased by -4.60% in the past year.
The Revenue has been growing slightly by 2.91% on average over the past years.
EPS 1Y (TTM)356.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%584.62%
Revenue 1Y (TTM)-4.6%
Revenue growth 3Y10.83%
Revenue growth 5Y2.91%
Sales Q2Q%-1.12%

3.2 Future

The Earnings Per Share is expected to grow by 40.34% on average over the next years. This is a very strong growth
CENX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.72% yearly.
EPS Next Y229.03%
EPS Next 2Y115.39%
EPS Next 3Y40.34%
EPS Next 5YN/A
Revenue Next Year-1.69%
Revenue Next 2Y4.96%
Revenue Next 3Y7.72%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.33 indicates a rather expensive valuation of CENX.
CENX's Price/Earnings ratio is a bit cheaper when compared to the industry. CENX is cheaper than 67.95% of the companies in the same industry.
CENX is valuated rather cheaply when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.75, CENX is valued correctly.
Based on the Price/Forward Earnings ratio, CENX is valued a bit cheaper than the industry average as 66.03% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CENX to the average of the S&P500 Index (22.83), we can say CENX is valued slightly cheaper.
Industry RankSector Rank
PE 18.33
Fwd PE 12.75

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CENX.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.47

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CENX's earnings are expected to grow with 40.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y115.39%
EPS Next 3Y40.34%

0

5. Dividend

5.1 Amount

No dividends for CENX!.
Industry RankSector Rank
Dividend Yield N/A

CENTURY ALUMINUM COMPANY

NASDAQ:CENX (12/20/2024, 8:01:20 PM)

After market: 18.33 0 (0%)

18.33

+0.27 (+1.5%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners82.65%
Inst Owner Change38.55%
Ins Owners61.78%
Ins Owner Change-0.09%
Market Cap1.70B
Analysts77.78
Price Target21.42 (16.86%)
Short Float %8.12%
Short Ratio3.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)4.76%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)10.85%
Revenue beat(4)2
Avg Revenue beat(4)3.05%
Min Revenue beat(4)-2.59%
Max Revenue beat(4)10.85%
Revenue beat(8)5
Avg Revenue beat(8)3.89%
Revenue beat(12)6
Avg Revenue beat(12)1.5%
Revenue beat(16)6
Avg Revenue beat(16)-0.21%
PT rev (1m)10.53%
PT rev (3m)13.51%
EPS NQ rev (1m)12%
EPS NQ rev (3m)223.08%
EPS NY rev (1m)24.22%
EPS NY rev (3m)47.06%
Revenue NQ rev (1m)-0.57%
Revenue NQ rev (3m)-1.2%
Revenue NY rev (1m)0.94%
Revenue NY rev (3m)-0.78%
Valuation
Industry RankSector Rank
PE 18.33
Fwd PE 12.75
P/S 0.81
P/FCF N/A
P/OCF 20.54
P/B 2.61
P/tB 2.61
EV/EBITDA 11.47
EPS(TTM)1
EY5.46%
EPS(NY)1.44
Fwd EY7.85%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0.89
OCFY4.87%
SpS22.65
BVpS7.03
TBVpS7.03
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.13%
ROE 46.91%
ROCE 7.08%
ROIC 5.56%
ROICexc 5.69%
ROICexgc 5.69%
OM 4.8%
PM (TTM) 14.55%
GM 7.52%
FCFM N/A
ROA(3y)-4.65%
ROA(5y)-5.63%
ROE(3y)-18.45%
ROE(5y)-17.98%
ROIC(3y)2.82%
ROIC(5y)N/A
ROICexc(3y)2.95%
ROICexc(5y)N/A
ROICexgc(3y)2.95%
ROICexgc(5y)N/A
ROCE(3y)3.59%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF N/A
Debt/EBITDA 2.47
Cap/Depr 120.43%
Cap/Sales 4.82%
Interest Coverage 2.88
Cash Conversion 44.76%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 0.56
Altman-Z 1.04
F-Score6
WACC11.08%
ROIC/WACC0.5
Cap/Depr(3y)115.08%
Cap/Depr(5y)86.6%
Cap/Sales(3y)3.74%
Cap/Sales(5y)3.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)356.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%584.62%
EPS Next Y229.03%
EPS Next 2Y115.39%
EPS Next 3Y40.34%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.6%
Revenue growth 3Y10.83%
Revenue growth 5Y2.91%
Sales Q2Q%-1.12%
Revenue Next Year-1.69%
Revenue Next 2Y4.96%
Revenue Next 3Y7.72%
Revenue Next 5YN/A
EBIT growth 1Y461.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year289.58%
EBIT Next 3Y56.32%
EBIT Next 5YN/A
FCF growth 1Y81.92%
FCF growth 3Y-28.91%
FCF growth 5YN/A
OCF growth 1Y1700%
OCF growth 3Y35.02%
OCF growth 5YN/A